Samarth Kulkarni

Chief Executive Officer · CRISPR Therapeutics

Samarth Kulkarni (Chief Executive Officer) filed 7 Form 4 reports in the trailing twelve months (0 purchases, 7 sales), most often in CRISPR Therapeutics AG (CRSP). The largest single filing was $5.2M of CRSP (90,000 sh across 3 lots, as filed), executed Jan 20. Data as of Nov 8 2026.

Add to watchlist

Return, ttmiAverage return per filing, trailing twelve months

–

no purchases on file

Delay-adjustediThe same average, entered at disclosure dates

–

returns measure stock purchases only

Filings, ttm

0 buys · 7 sells

Median delay

–

measured on stock purchases

Volume, ttmiDollar value disclosed in the trailing twelve months

$9.6M

shares × price, as filed

Last traded

Oct 19

Filed Oct 20

Median ADV $94.8M across their filed names

Open performance→

Volume by month

Buys $0 Sells $18.0M

Shares × price, as filed · by filing month · past 24 months

Sectors filed on

Healthcare 7 filings

Sector per market data · by filing · past 12 months

Most traded names

CRSP

CRISPR Therapeutics AG CRSP · 0 buys · 16 sells 16 filings

Recent filings

CRSPSALE CRISPR Therapeutics AG View filing → $2.4M
47,837 sh × $49.78
Exec Oct 19
Filed Oct 20 · 5:35 PM ET CRSPSALE CRISPR Therapeutics AG View filing → $202K
4,098 sh × $49.26
Exec Oct 14
Filed Oct 15 · 5:35 PM ET CRSPSALE CRISPR Therapeutics AG View filing → $469K
10,020 sh × $46.78
Exec Mar 23
Filed Mar 24 · 5:30 PM ET CRSPSALE CRISPR Therapeutics AG View filing → $499K
10,349 sh × $48.26
Exec Mar 16
Filed Mar 17 · 5:30 PM ET CRSPSALE CRISPR Therapeutics AG View filing → $517K
9,798 sh × $52.80
Exec Mar 11
Filed Mar 12 · 5:30 PM ET CRSPSALE CRISPR Therapeutics AG View filing → $366K
6,967 sh × $52.58
Exec Feb 19
Filed Feb 20 · 5:30 PM ET CRSPSALE CRISPR Therapeutics AG View filing → $5.2M
90,000 sh across 3 lots
Exec Jan 20
Filed Jan 22 · 5:30 PM ET CRSPSALE CRISPR Therapeutics AG View filing → $3.5M
50,895 sh × $67.91
Exec Oct 17 2025
Filed Oct 20 2025 · 5:30 PM ET More filings →